NewGenIvf Group Statistics
Total Valuation
NewGenIvf Group has a market cap or net worth of $4.45 million. The enterprise value is $6.54 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
NewGenIvf Group has 4.32 million shares outstanding. The number of shares has increased by 141.68% in one year.
| Current Share Class | 4.30M |
| Shares Outstanding | 4.32M |
| Shares Change (YoY) | +141.68% |
| Shares Change (QoQ) | +185.90% |
| Owned by Insiders (%) | 1.01% |
| Owned by Institutions (%) | 2.10% |
| Float | 4.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17
| Current Ratio | 1.17 |
| Quick Ratio | 1.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.49 |
Financial Efficiency
Return on equity (ROE) is -53.76% and return on invested capital (ROIC) is -27.47%.
| Return on Equity (ROE) | -53.76% |
| Return on Assets (ROA) | -17.99% |
| Return on Invested Capital (ROIC) | -27.47% |
| Return on Capital Employed (ROCE) | -135.35% |
| Revenue Per Employee | $71,492 |
| Profits Per Employee | -$6,903 |
| Employee Count | 76 |
| Asset Turnover | 1.35 |
| Inventory Turnover | 34.83 |
Taxes
| Income Tax | -486,706 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.49% in the last 52 weeks. The beta is 0.13, so NewGenIvf Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -99.49% |
| 50-Day Moving Average | 2.52 |
| 200-Day Moving Average | 61.25 |
| Relative Strength Index (RSI) | 32.26 |
| Average Volume (20 Days) | 9,092,694 |
Short Selling Information
The latest short interest is 367,548, so 8.50% of the outstanding shares have been sold short.
| Short Interest | 367,548 |
| Short Previous Month | 106,844 |
| Short % of Shares Out | 8.50% |
| Short % of Float | 8.59% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, NewGenIvf Group had revenue of $5.43 million and -$524,643 in losses. Loss per share was -$14.65.
| Revenue | 5.43M |
| Gross Profit | 1.83M |
| Operating Income | -1.16M |
| Pretax Income | n/a |
| Net Income | -524,643 |
| EBITDA | -1.14M |
| EBIT | -1.16M |
| Loss Per Share | -$14.65 |
Full Income StatementBalance Sheet
The company has $1.53 million in cash and $3.18 million in debt, giving a net cash position of -$1.65 million or -$0.38 per share.
| Cash & Cash Equivalents | 1.53M |
| Total Debt | 3.18M |
| Net Cash | -1.65M |
| Net Cash Per Share | -$0.38 |
| Equity (Book Value) | -1.48M |
| Book Value Per Share | -9.21 |
| Working Capital | 452,391 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.26 million and capital expenditures -$53,045, giving a free cash flow of -$8.32 million.
| Operating Cash Flow | -8.26M |
| Capital Expenditures | -53,045 |
| Free Cash Flow | -8.32M |
| FCF Per Share | -$1.92 |
Full Cash Flow StatementMargins
Gross margin is 33.62%, with operating and profit margins of -21.36% and -9.66%.
| Gross Margin | 33.62% |
| Operating Margin | -21.36% |
| Pretax Margin | -17.68% |
| Profit Margin | -9.66% |
| EBITDA Margin | -21.00% |
| EBIT Margin | -21.36% |
| FCF Margin | n/a |
Dividends & Yields
NewGenIvf Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -141.67% |
| Shareholder Yield | -141.67% |
| Earnings Yield | -10.74% |
| FCF Yield | -170.20% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 5, 2025. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | May 5, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
NewGenIvf Group has an Altman Z-Score of 1.86 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.86 |
| Piotroski F-Score | 1 |